Viewing data from:

LORTAB

ANDA

ACETAMINOPHEN; HYDROCODONE BITARTRATE | A040100 | UCB INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Lortab (2023)

Total Spending

$48K

Total Claims

168

Beneficiaries

Avg Cost/Unit

$0.42

Spending Trend

$393K(2019)→$315K(2020)→$214K(2021)→$173K(2022)→$48K(2023)

YoY Change:+0.8%

5yr CAGR:-0.1%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 500MG;10MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jan 26, 1996

No patent or exclusivity listings for this strength.